Vasoactive drugs in the management of acute variceal bleeding

Several methods have been used to treat acute variceal hemorrhage. Sclerotherapy is the method of choice. The use of vasoactive drugs is popular despite unsatisfactory effect and systemic hemodynamic adverse effects. The recently introduced longacting somatostatin analogue, octreotide, is more effec...

Full description

Bibliographic Details
Main Author: Beauchant Michel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 1997-01-01
Series:The Saudi Journal of Gastroenterology
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=1997;volume=3;issue=1;spage=3;epage=7;aulast=Beauchant
_version_ 1818675758676049920
author Beauchant Michel
author_facet Beauchant Michel
author_sort Beauchant Michel
collection DOAJ
description Several methods have been used to treat acute variceal hemorrhage. Sclerotherapy is the method of choice. The use of vasoactive drugs is popular despite unsatisfactory effect and systemic hemodynamic adverse effects. The recently introduced longacting somatostatin analogue, octreotide, is more effective and has no systemic adverse effects. It may be used while waiting for emergency sclerotherapy or in combination with sclerotherapy in patients with high risk of rebleeding.
first_indexed 2024-12-17T08:32:40Z
format Article
id doaj.art-f0685d04dc4a4454a8a265de1a9f84dd
institution Directory Open Access Journal
issn 1319-3767
language English
last_indexed 2024-12-17T08:32:40Z
publishDate 1997-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series The Saudi Journal of Gastroenterology
spelling doaj.art-f0685d04dc4a4454a8a265de1a9f84dd2022-12-21T21:56:34ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671997-01-013137Vasoactive drugs in the management of acute variceal bleedingBeauchant MichelSeveral methods have been used to treat acute variceal hemorrhage. Sclerotherapy is the method of choice. The use of vasoactive drugs is popular despite unsatisfactory effect and systemic hemodynamic adverse effects. The recently introduced longacting somatostatin analogue, octreotide, is more effective and has no systemic adverse effects. It may be used while waiting for emergency sclerotherapy or in combination with sclerotherapy in patients with high risk of rebleeding.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=1997;volume=3;issue=1;spage=3;epage=7;aulast=Beauchant
spellingShingle Beauchant Michel
Vasoactive drugs in the management of acute variceal bleeding
The Saudi Journal of Gastroenterology
title Vasoactive drugs in the management of acute variceal bleeding
title_full Vasoactive drugs in the management of acute variceal bleeding
title_fullStr Vasoactive drugs in the management of acute variceal bleeding
title_full_unstemmed Vasoactive drugs in the management of acute variceal bleeding
title_short Vasoactive drugs in the management of acute variceal bleeding
title_sort vasoactive drugs in the management of acute variceal bleeding
url http://www.saudijgastro.com/article.asp?issn=1319-3767;year=1997;volume=3;issue=1;spage=3;epage=7;aulast=Beauchant
work_keys_str_mv AT beauchantmichel vasoactivedrugsinthemanagementofacutevaricealbleeding